We are live on ! Find out more
NVNOW

enVVeno Medical Corporation Warrants

Delisted

NVNOW was delisted on the 26th of May, 2023.

3 hedge funds and large institutions have $1K invested in enVVeno Medical Corporation Warrants in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding

Funds holding: 13 (+2)

Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
PAG
1
Private Advisor Group
New Jersey
$1K +$1.19K +10,000 New
NFSG
2
Newbridge Financial Services Group
Florida
+$59 +500 New
UBS Group
3
UBS Group
Switzerland
+$397 +3,340 +257%

NVNOW Hedge Fund Activity: Q3 2020 in Review

3 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q3 2020, worth a combined $1K.

Buyers outnumbered sellers: 2 funds opened new NVNOW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Private Advisor Group, opening a new position worth an estimated $1.19K.

  • 3 institutional investors held enVVeno Medical Corporation Warrants (NVNOW) as of Q3 2020, up from 1 in Q2 2020.
  • Funds reported $1K of enVVeno Medical Corporation Warrants stock for Q3 2020.
  • 2 funds opened new enVVeno Medical Corporation Warrants positions in Q3 2020 and 0 closed out, a net change of +2 holders.
  • The largest enVVeno Medical Corporation Warrants buyer in Q3 2020 was Private Advisor Group, an estimated $1.19K added.

Based on aggregated 13F filings for Q3 2020.